Recursion Pharmaceuticals, Inc.

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC RXRX

Report date

3/31/2026

Quarter

2026 Q1

Filed

4/8/2026

Shares

34,278

Value ($000)

107

Weight

0.0%

2024 Q4 - 2026 Q1 (6 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	4/8/2026	107	0.0%	34,278	3/31/2026
2025 Q4	1/8/2026	92	0.0%	20,210	12/31/2025
2025 Q3	10/29/2025	100	0.0%	19,096	9/30/2025
2025 Q2	7/10/2025	57	0.0%	10,910	6/30/2025
2025 Q1	4/16/2025	128	0.0%	24,230	3/31/2025
2024 Q4	3/17/2025	128	0.0%	18,952	12/31/2024